SCHEDULE

Time
Topic
Speaker
5 minutes
Welcome and introduction
Dr Christina Cheung
Department of Medicine and Therapeutics,
The Chinese University of Hong Kong
25 minutes
Itching and the JAK-STAT pathway
Prof. Brian Kim
Icahn School of Medicine, The Mount Sinai Hospital, New York
20 minutes
Case discussion: Real-world experience with
abrocitinib in Asia
Case study presented by Dr Wai-Leong Kok,
Starmed Specialist Centre, Singapore
All speakers and chair to join discussion on patient
cases and answer questions on practical use of abrocitinib
10 minutes
Panel discussion
All

WEBINAR SESSION AND TIMES

11 January 2024
Country Time
Taiwan, Hong Kong20:00–21:00 (GMT +8)
Thailand19:00–20:00 (GMT +7)
Mumbai, India17:30–18:30 (GMT +5:30)
AGENDAFACULTY INFO

Itching and atopic dermatitis:
How can abrocitinib transform
symptom management?

OBJECTIVES

Explore the mechanisms of itching in
atopic dermatitis and how disrupting
the JAK-STAT pathway can improve
symptoms (including IL-33 pathway)

Provide insights into real-word
experience with abrocitinib to
improve itching